Hyku Biosciences
Latest round
- Seed
Last raised
- Sep 2023
Total raised
- $56M
Investors
- 6
About Hyku Biosciences
Based in Massachusetts, US, and founded by Milind Deshpande, Hyku Biosciences, Inc. operates as a research and development medical company that finds substances that covalently link non-cysteine amino acids to create novel treatments for diseases like cancer. In September 2023, Hyku Biosciences, Inc. The company offers a proprietary Hyku platform, which identifies and leverages compounds capable of covalently binding to non-cysteine amino acids. This enables the development of novel therapies that address the inherent challenges associated with numerous disease targets, including issues related to selectivity, druggability, and resistance. Through rigorous scientific exploration and an unwavering commitment to progress, Hyku has become a leading force in the quest to transform conventional treatment paradigms. This multidisciplinary approach enables the company to identify and develop small-molecule therapeutics against a diverse range of drug targets, ultimately aimed at improving patient lives.
Who invested in Hyku Biosciences
6 investors across 1 round
See all investors in Hyku Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 19, 2023
Amount
$56M
Investors
Questions about Hyku Biosciences
Who invested in Hyku Biosciences?
Hyku Biosciences has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hyku Biosciences raised?
Hyku Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hyku Biosciences last raise money?
Hyku Biosciences's most recent round on record is a Seed, in Sep 2023.
What does Hyku Biosciences do?
Based in Massachusetts, US, and founded by Milind Deshpande, Hyku Biosciences, Inc.
Where is Hyku Biosciences headquartered?
Hyku Biosciences is headquartered in Lexington, US.
Which VCs invest in companies like Hyku Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Hyku Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Hyku Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.